Loading: 100%
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reasons:
- It is not known how cost items are reported in the original P&L
- Not all line items from the original statement have been associated with a standardised figure (19 items missing)
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Product, accessories and parts
0
0
0
0
124
105
73
Service
0
0
0
0
10
11
12
Total revenue
62
82
109
128
133
115
85
Product, accessories and parts
0
0
0
0
103
89
62
Service
0
0
0
0
8
9
11
Total cost of goods sold
70
82
104
113
111
97
72
Gross margin
-8
-1
5
14
22
18
13
Research and development
7
7
8
9
9
10
10
Selling, general and administrative
28
26
29
27
28
40
27
Total operating expenses
35
33
37
36
37
49
37
Loss from operations
-44
-34
-32
-22
-15
-31
-24
Interest income
0
0
0
0
0
0
0
Other (expense) income
0
0
0
0
0
0
0
Interest expense
-1
-1
-1
-1
-1
-1
-1
Change in fair value of warrant liability
-23
-4
14
1
0
0
0
Loss before income taxes
-67
-38
-19
-22
-16
-31
-25
Provision for income taxes
0
0
0
1
0
0
0
Net loss
-67
-38
-19
-23
-16
-32
-25
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Jun 9, 2016 n/a
calculated values,
restated on Jun 9, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Balance SheetBS data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (30 items missing)
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash and cash equivalents
n/a
33
50
39
28
32
12
Restricted cash
n/a
0
0
0
0
0
5
Accounts receivable, net of allowances of $11,041 at March 31, 2015 and $2,246 at March 31, 2014
n/a
19
19
18
28
13
14
Inventories
n/a
19
19
19
18
23
16
Prepaid expenses and other current assets
n/a
2
3
3
2
3
3
Total current assets
n/a
74
90
78
76
72
49
Property, plant and equipment, net
n/a
6
5
4
3
4
4
Non-current portion of inventories
n/a
1
1
3
3
2
2
Restricted Cash and Cash Equivalents, Noncurrent
n/a
1
0
0
0
0
0
Intangible assets, net
n/a
4
3
2
2
1
1
Other assets
n/a
0
0
0
0
0
0
Total
n/a
87
100
87
84
79
56
Liabilities and owners' equity
Accounts payable and accrued expenses
n/a
20 20292000
23 23061000
24 24121000
29 28577000
22 22266000
13 13187000
Accrued salaries and wages
n/a
2 1555000
2 1716000
2 1721000
2 1883000
2 2113000
2 1880000
Accrued warranty reserve
n/a
1 1081000
1 1494000
2 2299000
3 2965000
3 3183000
2 1639000
Deferred revenue
n/a
1 1153000
3 2995000
3 3089000
3 2657000
3 3051000
4 4368000
Revolving credit facility
n/a
7 7080000
10 10431000
13 13476000
13 13228000
13 12953000
9 9459000
Current portion of notes payable and capital lease obligations
n/a
0 214000
0 363000
0 361000
0 444000
0 407000
0 361000
Warrant liability
n/a
21 20772000
1 791000
0 10000
0 0
0 0
0 0
Total current liabilities
n/a
52 52147000
41 40851000
45 45077000
50 49754000
44 43973000
31 30894000
Long-term portion of notes payable and capital lease obligations
n/a
0 83000
0 70000
0 233000
0 201000
0 89000
0 74000
Other long-term liabilities
n/a
0 309000
0 254000
0 142000
0 70000
0 161000
0 184000
Commitments and contingencies (Note 15)
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Preferred stock, $.001 par value; 10,000,000 shares authorized; none issued
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Common stock, $.001 par value; 515,000,000 shares authorized, 23,857,516 shares issued and 23,753,873 shares outstanding at March 31, 2016; 16,590,058 shares issued and 16,527,264
n/a
0 260000
0 300000
0 306000
0 312000
0 17000
0 24000
Additional paid-in capital
n/a
748 747962000
791 790901000
797 796767000
805 805342000
838 837965000
853 853288000
Accumulated deficit
n/a
-713 -712648000
-731 -731412000
-754 -753975000
-770 -770231000
-802 -801764000
-827 -826955000
Treasury stock, at cost; 103,643 shares at March 31, 2016 and 62,794 shares at March 31, 2015
n/a
-1 -1094000
-1 -1172000
-1 -1212000
-1 -1330000
-2 -1514000
-2 -1617000
Total stockholders' equity
n/a
34 34480000
59 58617000
42 41886000
34 34093000
35 34704000
25 24740000
Total
n/a
87 87019000
100 99792000
87 87338000
84 84118000
79 78927000
56 55892000
Remarks restated on n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Nov 30, -1 n/a restated on Jun 9, 2016 n/a restated on Nov 30, -1 n/a
Cash Flow StatementCF data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
- Not all line items from the original statement have been associated with a standardised figure (34 items missing)
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net loss
-67
-38
-19
-23
-16
-32
-25
Depreciation and amortization
3
4
3
3
2
2
2
Amortization of deferred financing costs
0
0
0
0
0
0
0
Interest on restricted cash
0
0
0
0
0
0
0
Accounts receivable allowances
0
0
2
0
0
10
-1
Inventory provision
1
1
2
1
2
3
2
Provision for warranty expenses
1
2
4
5
4
3
0
Loss on disposal of equipment
0
0
0
0
0
0
0
Stock-based compensation
5
2
2
2
2
2
3
Interest expense on second funding liability
0
0
0
0
0
0
0
Change in fair value of warrant liability
23
4
-14
-1
0
0
0
Accounts receivable
-8
-1
-2
0
-10
5
1
Inventories
6
2
-1
-3
-1
-7
5
Prepaid expenses and other current assets
0
-1
0
1
0
-1
0
Accounts payable and accrued expenses
4
5
3
1
4
-6
-8
Accrued salaries and wages and long term liabilities
0
0
0
0
0
0
0
Accrued warranty reserve
-3
-2
-4
-4
-3
-3
-2
Deferred revenue
0
0
2
0
0
0
1
Increase (Decrease) in Other Operating Liabilities
-1
0
0
0
0
0
0
Net cash used in operating activities
-35
-22
-21
-17
-15
-23
-22
Expenditures for property and equipment
-2
-1
-1
-1
-1
-2
-2
Net cash used in investing activities
-2
-2
0
-1
-1
-2
-2
Net proceeds from (repayments of) revolving credit facility
0
0
3
3
0
0
-3
Changes in restricted cash
0
-1
1
0
0
0
-5
Repayment of notes payable and capital lease obligations
0
0
0
0
0
-1
-1
Net proceeds from ( cash used in) provided by employee stock-based transactions
0
0
1
0
0
0
0
Net proceeds from equity issuances
7
11
11
4
6
30
13
Net proceeds from issuance of common stock
54
0
23
0
0
0
0
Net cash (used in) provided by financing activities
64
10
38
7
6
29
3
Payments of Financing Costs
0
0
0
0
0
0
0
Net proceeds from revolving credit facility
4
0
0
0
0
0
0
Net (decrease) increase in cash and cash equivalents
28
-14
16
-11
-11
4
-21
Remarks
restated on Nov 30, -1 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
restated on Jun 12, 2014 n/a
calculated values,
restated on Jun 15, 2015 n/a
calculated values,
restated on Jun 9, 2016 n/a
calculated values,
restated on Jun 9, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,